Open Access
Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression
Oncotarget · 06.01.2026 · 17 (1) · 250-250
DOI: 10.18632/oncotarget.28885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Yueli Gu und 2 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gu, Y., Xiao, X., & Yang, S. (2026). Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression. Oncotarget, 17(1), 250-250. https://doi.org/10.18632/oncotarget.28885
Vancouver
Gu Y, Xiao X, Yang S. Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression. Oncotarget. 2026;17(1):250-250. doi:10.18632/oncotarget.28885
BibTeX
@article{Gu2026,
author = {Gu, Yueli and Xiao, Xichun and Yang, Shuo},
title = {Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {250--250},
doi = {10.18632/oncotarget.28885}
}
EUVIMED